Fundz

ChronicleBio Appoints Dr. John Mumm as Chief Scientific Officer

PRIVATEJun 11, 2026

Position

Chief Scientific Officer

Company

ChronicleBio

John Mumm
Menlo ParkBiotechnologyHealth CareArtificial Intelligence

Description

ChronicleBio has announced the appointment of Dr. John Mumm as Chief Scientific Officer. Mumm, a seasoned immunology innovator, brings extensive expertise to the company as it aims to address neuroimmune conditions.

Quick answer

ChronicleBio Appoints Dr. John Mumm as Chief Scientific Officer (June 11, 2026). ChronicleBio is based in Menlo Park, California, United States.

Who is the new Chief Scientific Officer at ChronicleBio?
ChronicleBio named John Mumm Chief Scientific Officer, announced June 11, 2026.
What did ChronicleBio announce on June 11, 2026?
ChronicleBio has announced the appointment of Dr. John Mumm as Chief Scientific Officer. Mumm, a seasoned immunology innovator, brings extensive expertise to the company as it aims to address neuroimmune conditions.
What does ChronicleBio do?
ChronicleBio is a data-driven techbio company utilizing advances in multi-omics and artificial intelligence.
Where is ChronicleBio based?
ChronicleBio is based in Menlo Park, California, United States.
Which similar companies made leadership changes around the same time?
Hoppr (June 9, 2026), Acurion (June 17, 2026), Change Agents Corporation. (June 4, 2026) and Rhythm AI (June 2, 2026) also announced leadership changes within 45 days of ChronicleBio.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at ChronicleBio, and when

A new leader at ChronicleBio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day ChronicleBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ChronicleBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ChronicleBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ChronicleBio

Location

1080 O'Brien Drive, Suite B

Menlo Park, California, United States

About

ChronicleBio is a data-driven techbio company utilizing advances in multi-omics and artificial intelligence. The company is focused on transforming drug development for neuroimmune conditions that have traditionally been viewed as incurable. Their mission is to change how chronic diseases are understood and treated, aiming to improve outcomes for millions of patients. ChronicleBio combines innovative biological research with cutting-edge technology to offer tailored therapeutic solutions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ChronicleBio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Rishi
Senior decision-maker at this company
••••••••@••••••••

See Rishi's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for ChronicleBio's next move

Learn about Strategic plan

ChronicleBio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.